Edge Therapeutics Raises $72M For Brain Injury Drug
Clinical-stage biotech Edge Therapeutics Inc. said Thursday it has raised roughly $72.5 million in venture capital investment in two recent private financing rounds that will fund the development of its brain...To view the full article, register now.
Already a subscriber? Click here to view full article